Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) (TAK) closed at $21.64 on November 17, 2026, up 0.2% from the previous close, on volume of 2,586,412 shares (30-day average 2,923,590).
Data as of November 17, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 16, 2026. See the largest for 5, 30, 60 and 90 days
Takeda Updates Real-World Crohn’s Disease Study as Investors Watch Darvadstrocel Data
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda Updates Real-World Study of Maribavir in Transplant Patients
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda Updates Real-World TAKHZYRO Study in Hereditary Angioedema
TipRanks (Thu, 12-Nov 11:32 AM ET)
Takeda launches new narcolepsy pill as DEA completes scheduling
Seeking Alpha News (Thu, 12-Nov 8:42 AM ET)
Business Wire (Thu, 12-Nov 7:35 AM ET)
Takeda spotlights ORZEYFUL approvals and raises FY2026 forecast as reported operating profit jumps
Market Chameleon (Fri, 30-Oct 7:53 AM ET)
Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones
Business Wire (Thu, 29-Oct 2:36 AM ET)
Business Wire (Fri, 23-Oct 7:30 AM ET)
Business Wire (Mon, 19-Oct 5:30 AM ET)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) trades on the NYSE stock market under the symbol TAK.
As of November 17, 2026, TAK stock price climbed to $21.64 with 2,586,412 million shares trading.
TAK has a beta of 0.03, meaning it tends to be less sensitive to market movements. TAK has a correlation of 0.00 to the broad based SPY ETF.
TAK has a market cap of $69.11 billion. This is considered a Large Cap stock.
Last quarter Takeda Pharmaceutical Company Limited American Depositary Shares (Each Representing 1/2 Of A Share Of Common Stock) reported $7 billion in Revenue and $.48 earnings per share. This beat revenue expectation by $267 million and exceeded earnings estimates by $.17.
In the last 3 years, TAK traded as high as $21.86 and as low as $12.58.
The top ETF exchange traded funds that TAK belongs to (by Net Assets): FVD, PPH, AVDE, IDVO, APIE.
TAK has outperformed the market in the last year with a price return of +51.4% while the SPY ETF gained +10.1%. TAK has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +22.7% and +3.7%, respectively, while the SPY returned -5.4% and -2.6%, respectively.
TAK support price is $21.24 and resistance is $21.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TAK shares will trade within this expected range on the day.